Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside ototoxicity

S A Lerner, G J Matz

    American Journal of Otolaryngology
    |February 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Aminoglycoside antibiotics treat serious infections but risk hearing and kidney damage. Optimizing dosage using pharmacokinetic data and monitoring levels minimizes these toxic effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multilayer-coating-induced aberrations in extreme-ultraviolet lithography optics.

    Applied optics·2008
    Same author

    Ray and van cittert-zernike characterization of spatial coherence.

    Applied optics·2008
    Same author

    Optical design with parametrically defined aspheric surfaces.

    Applied optics·2008
    Same author

    Rare presentation of Streptococcus pneumoniae pneumonia with bacteremia and multiple subcutaneous abscesses.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2002
    Same author

    Aminoglycoside ototoxicity: a human temporal bone study.

    The Laryngoscope·2002
    Same author

    Conjoint molecules of cephalosporins and aminoglycosides.

    Archiv der Pharmazie·2001
    Same journal

    Re: Sarcopenia and postoperative morbidity in head and neck cancer: a systematic review and meta-analysis.

    American journal of otolaryngology·2026
    Same journal

    Epistaxis burden in hereditary hemorrhagic telangiectasia: Validation and refinement of the NOSE-HHT.

    American journal of otolaryngology·2026
    Same journal

    An assessment of pharmacologic deep vein thrombosis prophylaxis on head and neck free flap outcomes.

    American journal of otolaryngology·2026
    Same journal

    Rapid improvement of nasal obstruction after treatment with a non-vasoconstrictive osmotic nasal spray: A prospective observational study.

    American journal of otolaryngology·2026
    Same journal

    Evaluation of systemic inflammation in sinonasal inverted papilloma using hematological and biochemical markers.

    American journal of otolaryngology·2026
    Same journal

    The impact of race and ethnicity on cochlear implant outcomes.

    American journal of otolaryngology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Nephrology
    • Otolaryngology

    Background:

    • Aminoglycoside antibiotics are crucial for treating infections from aerobic gram-negative bacilli.
    • Their clinical utility is constrained by potential ototoxicity and nephrotoxicity.
    • These antibiotics are eliminated via glomerular filtration, with clearance linked to serum concentration.

    Purpose of the Study:

    • To optimize aminoglycoside administration for maximum therapeutic efficacy.
    • To minimize the risk of ototoxicity and nephrotoxicity associated with aminoglycoside use.
    • To guide physicians in managing aminoglycoside therapy based on pharmacokinetic data and patient-specific factors.

    Main Methods:

    • Utilizing aminoglycoside pharmacokinetic data.
    • Assessing pathogen susceptibility to aminoglycosides.

    Related Experiment Videos

  • Identifying risk factors for ototoxicity.
  • Periodic monitoring of renal function and serum aminoglycoside levels.

    • Main Results:

    • Optimized administration strategies can enhance therapeutic outcomes.
    • Close monitoring of renal function and drug levels is essential for safe use.
    • Informed management can reduce the incidence and severity of toxic side effects.

    Conclusions:

    • Physicians can balance the benefits and risks of aminoglycosides by integrating pharmacokinetic knowledge, susceptibility data, and risk factor assessment.
    • Regular monitoring of renal function and serum concentrations is critical for guiding safe and effective aminoglycoside therapy.
    • Otolaryngologists and audiologists play a vital role in educating medical colleagues and managing patients experiencing ototoxicity.